Feed CMRA
CM

Comera Life Sciences Holdings, Inc.

CMRA · OTC

$0.00 +0.00% (+$0.00)
Analiza

AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.

Piotroski F-Score Weak
2/9
Valuation
-
N/A
P/FCF N/A
P/S N/A
P/B N/A
Growth
-
N/A
Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A
Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A
ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A
Debt/Assets N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
74 /100
Stable
Beta 1.11x
EPS volatility N/A
Profitable years N/A

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o CMRA
Online

O podjetju

Comera Life Sciences Holdings, Inc. (CLSH) is a biotechnology company specializing in the research and development of therapeutic products aimed at improving human health. With a passion for innovation and scientific advancement, CLSH strives to find new ways of treating and preventing various diseases. Their expert team works on discovering biomarkers and therapeutic targets that can provide new perspectives in medicine. The company is known for its commitment to scientific excellence and ethical standards in research. Comera Life Sciences Holdings, Inc. (CLSH) shares could be suitable for investors interested in the biotechnology sector and supporting innovations aimed at enhancing human health.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Biotechnology

CEO

Michael G. Campbell

Employees

12

Headquarters

Woburn

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.